IR@PKUHSC  > 北京大学第二临床医学院
学科主题临床医学
Superior Survival with VMP Versus MP After Longer Follow-up and Response to Subsequent Therapy in VISTA
San Miguel, J.1; Dimopoulos, M. A.1; Schlag, R.2; Khuageva, N.3; Shpilberg, O.4; Kropff, M.5; Spicka, I.6; Petrucci, M.7; Palumbo, A.8; Samoilova, O.9; Dmoszynska, A.10; Abdulkadyrov, K.11; Schots, R.; Jiang, B.12; Mateos, M. V.13; Anderson, K. C.14; Esseltine, D. L.15; Liu, K.16; Cakana, A.17; van de Velde, H.18; Richardson, P. G.14
刊名CLINICAL LYMPHOMA & MYELOMA
2009-02-01
9页:S39-S40
收录类别SCI
文章类型Meeting Abstract
WOS标题词Science & Technology
类目[WOS]Oncology
研究领域[WOS]Oncology
语种英语
WOS记录号WOS:000268206500086
Citation statistics
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/67763
Collection北京大学第二临床医学院
作者单位1.Univ Roma La Sapienza, Rome, Italy
2.Univ Turin, I-10124 Turin, Italy
3.Nizhnii Novgorod Reg Clin Hosp, Nizhnii Novgorod, Russia
4.Med Univ Lublin, Lublin, Poland
5.St Petersburg Clin Res Inst Hematol & Transfusiol, St Petersburg, Russia
6.Peking Univ, Peoples Hosp, Beijing, Peoples R China
7.Rabin Med Ctr, Petah Tiqwa, Israel
8.Univ Munster, D-4400 Munster, Germany
9.Univ Hosp, Prague, Czech Republic
10.Univ Athens, Sch Med, GR-10679 Athens, Greece
11.Praxisklin Dr Schlag, Wurzburg, Germany
12.SP Botkin Moscow City Clin Hosp, Moscow, Russia
13.Hosp Univ Salamanca, CIC, IBMCC, USAL CSIC, Salamanca, Spain
14.Dana Farber Canc Inst, Boston, MA 02115 USA
15.Millennium Takeda Oncol Co, Cambridge, MA USA
16.Johnson & Johnson Pharmaceut Res & Dev LLC, Raritan, NJ USA
17.Johnson & Johnson Pharmaceut Res & Dev, High Wycombe, Bucks, England
18.Johnson & Johnson Pharmaceut Res & Dev, Beerse, Belgium
Recommended Citation
GB/T 7714
San Miguel, J.,Dimopoulos, M. A.,Schlag, R.,et al. Superior Survival with VMP Versus MP After Longer Follow-up and Response to Subsequent Therapy in VISTA[J]. CLINICAL LYMPHOMA & MYELOMA,2009,9:S39-S40.
APA San Miguel, J..,Dimopoulos, M. A..,Schlag, R..,Khuageva, N..,Shpilberg, O..,...&Richardson, P. G..(2009).Superior Survival with VMP Versus MP After Longer Follow-up and Response to Subsequent Therapy in VISTA.CLINICAL LYMPHOMA & MYELOMA,9,S39-S40.
MLA San Miguel, J.,et al."Superior Survival with VMP Versus MP After Longer Follow-up and Response to Subsequent Therapy in VISTA".CLINICAL LYMPHOMA & MYELOMA 9(2009):S39-S40.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
谷歌学术
谷歌学术Similar articles in
[San Miguel, J.]'s Articles
[Dimopoulos, M. A.]'s Articles
[Schlag, R.]'s Articles
百度学术
百度学术Similar articles in
[San Miguel, J.]'s Articles
[Dimopoulos, M. A.]'s Articles
[Schlag, R.]'s Articles
必应学术
必应学术Similar articles in
[San Miguel, J.]'s Articles
[Dimopoulos, M. A.]'s Articles
[Schlag, R.]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.